Alliance A091102: Phase II study of MLN8237 (alisertib) in advanced/metastatic sarcoma.
Mark Andrew Dickson
No relevant relationships to disclose
Michelle R. Mahoney
No relevant relationships to disclose
Benjamin T. Marchello
No relevant relationships to disclose
Mercedes M. Condy
No relevant relationships to disclose
William D. Tap
No relevant relationships to disclose
Gary K. Schwartz
No relevant relationships to disclose